Pharma logistics: Fiege Switzerland receives Swissmedic re-certification

Münchenstein. The Swiss Regionales Heilmittelinspektorat (RHI), which carries out inspections on behalf of Swissmedic, has audited Fiege’s site in Münchenstein. With the successful re-certification, Fiege Logistik (Schweiz) AG has once again demonstrated its competence in the area of pharmaceutical logistics (wholesale and manufacture).

This re-confirms that Fiege meets the essential requirements for official approval regarding the provision of high-quality pharmaceutical services. These include manufacturing stages in a dedicated clean room, for example. Swissmedic is the central Swiss authority responsible for the authorisation and supervision of therapeutic products. Swissmedic’s activities are based on the Law on Therapeutic Products. Swissmedic is attached to the Federal Department of Home Affairs.

About the
FIEGE Group

The Fiege Group, headquartered in Greven/Germany, is one of Europe’s leading logistics providers. Its competence lies particularly in the development and realisation of integrated supply chain systems, and it is considered a pioneer of contract logistics. In 2016, the Group generated a turnover of Euro 1.45 billion world-wide with a workforce of 12,338. 178 locations and co-operations based in 15 countries form a dense supply-chain network. 2.8 million square metres of warehouse and logistics space vouch for the company’s efficiency.